Stocks and Investing
Stocks and Investing
Wed, November 6, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, November 5, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tiago Fauth Initiated (APLS) at Hold and Held Target at $33 on, Nov 5th, 2019
Tiago Fauth of Credit Suisse, Initiated "Apellis Pharmaceuticals, Inc." (APLS) at Hold and Held Target at $33 on, Nov 5th, 2019.
Tiago has made no other calls on APLS in the last 4 months.
There is 1 other peer that has a rating on APLS. Out of the 1 peers that are also analyzing APLS, 0 agree with Tiago's Rating of Hold.
This is the rating of the analyst that currently disagrees with Tiago
- Anupam Rama of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $49 on, Friday, July 12th, 2019
Contributing Sources